Delivery Order SPE2DP20D0002-SPE2DP23F2820
Award Date
3/22/23
Potential Completion Date
3/28/23
Potential Value
$305K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4 from March 22, 2023 through March 28, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its place of performance in Parsippany, New Jersey.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $458,090.64 firm fixed price delivery order contract to provide adenovirus type 4 from April 19, 2023 through April 25, 2023. Teva Pharmaceuticals USA, Inc. will perform the contract from its place of performance in Parsippany, New Jersey.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4 from January 18, 2023 through January 24, 2023. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The contract period of performance spans from April 19, 2023 through April 25, 2023. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4. The place of performance for this January 18-24, 2023 contract is Teva Pharmaceuticals' facility located in Parsippany, New Jersey.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4. Teva Pharmaceuticals USA, Inc. will perform all work as the prime contractor, with the place of performance listed as Parsippany, New Jersey. The period of performance for this contract is from March 22, 2023 through March 28, 2023.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The contract period of performance spans from April 19, 2023 through April 25, 2023. No subcontractors were identified.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide adenovirus type 4. The place of performance for this January 18-24, 2023 contract is Teva Pharmaceuticals' facility located in Parsippany, New Jersey.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $282,353.76 firm fixed price delivery order contract to provide Adenovirus Type 4. The prime contractor, Teva Pharmaceuticals USA, Inc., is located in Parsippany, New Jersey and will perform the work at that location from December 7, 2021 through December 14, 2021.</p>
<p>The Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $305,393.76 firm fixed price delivery order contract to provide Adenovirus Type 4. The place of performance will be Teva Pharmaceuticals' facility located in Parsippany, New Jersey. The contract period of performance spans from April 19, 2023 through April 25, 2023. No subcontractors were identified.</p>